Brain glucose responses diminish with diabetes, obesity

November 20, 2017

(HealthDay)—The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus (T2DM), according to a study published online Oct. 19 in JCI Insight.

Janice J. Hwang, M.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues conducted 1H magnetic resonance spectroscopy scanning of the occipital lobe to measure the change in intracerebral glucose levels during a two-hour hyperglycemic clamp (glucose ~220 mg/dl) among 25 participants (nine healthy participants, 10 obese participants without diabetes, and six patients with poorly controlled, insulin- and metformin-treated T2DM).

The researchers found that after they controlled for age and sex, despite similar plasma at baseline and during hyperglycemia, the change in intracerebral glucose was significantly different across groups. Brain glucose increments were lower in participants with obesity and T2DM compared with lean participants. In addition, during hyperglycemia, the change in brain glucose was inversely correlated with plasma free fatty acid levels.

"These data suggest that obesity and poorly controlled T2DM progressively diminish brain responses to hyperglycemia, which has important implications for understanding not only the altered feeding behavior, but also the adverse neurocognitive consequences associated with and T2DM," conclude the authors.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Lower brain glucose levels found in people with obesity, type 2 diabetes

More information: Abstract/Full Text

Related Stories

Lower brain glucose levels found in people with obesity, type 2 diabetes

October 19, 2017
Glucose levels are reduced in the brains of individuals with obesity and type 2 diabetes compared to lean individuals, according to a new Yale study. The finding might explain disordered eating behavior—and even a higher ...

Addition of DPP4i to AGI reduces HbA1c in T2DM

October 5, 2017
(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), inadequately controlled with alpha-glucosidase inhibitors (AGIs), the addition of a dipeptidyl peptidase-4 (DPP4) inhibitor (DPP4i) is associated with a greater ...

Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

January 9, 2017
(HealthDay)—Resistance to the antilipolytic effect of insulin (Adipo-IR) is increased in obese individuals with normal glucose tolerance (NGT), and in those with impaired glucose tolerance (IGT) and type 2 diabetes (T2DM), ...

Similar defects ID'd for T2DM, chronic pancreatitis and diabetes

August 2, 2017
(HealthDay)—Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia, according to a study published online ...

Tofogliflozin most effective with high baseline insulin

October 24, 2017
(HealthDay)—The sodium glucose co-transporter 2 inhibitor tofogliflozin is effective for reducing fasting plasma glucose and body weight, particularly in patients with a high insulin level at baseline, according to a study ...

Gemigliptin, metformin combo beats monotherapy in T2DM

September 20, 2016
(HealthDay)—Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 13 in Diabetes, Obesity and Metabolism.

Recommended for you

Personalized blood sugar goals can save diabetes patients thousands

December 11, 2017
A cost analysis by researchers at the University of Chicago Medicine shows treatment plans that set individualized blood sugar goals for diabetes patients, tailored to their age and health history, can save $13,546 in health ...

Kidney disease increases risk of diabetes, study shows

December 11, 2017
Diabetes is known to increase a person's risk of kidney disease. Now, a new study from Washington University School of Medicine in St. Louis suggests that the converse also is true: Kidney dysfunction increases the risk of ...

Type 2 diabetes is not for life

December 5, 2017
Almost half of the patients with Type 2 diabetes supported by their GPs on a weight loss programme were able to reverse their diabetes in a year, a study has found.

Skipping breakfast disrupts 'clock genes' that regulate body weight

November 30, 2017
Irregular eating habits such as skipping breakfast are often associated with obesity, type 2 diabetes, hypertension and cardiovascular disease, but the precise impact of meal times on the body's internal clock has been less ...

Type 2 diabetes has hepatic origins

November 28, 2017
Affecting as many as 650 million people worldwide, obesity has become one of the most serious global health issues. Among its detrimental effects, it increases the risk of developing metabolic conditions, and primarily type ...

Critical link between obesity and diabetes has been identified

November 28, 2017
UT Southwestern researchers have identified a major mechanism by which obesity causes type 2 diabetes, which is a common complication of being overweight that afflicts more than 30 million Americans and over 400 million ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.